Home > Insider Trading > Filing (0000899243-21-014635)

Filing Details

Accession Number:: 0000899243-21-014635
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-02 18:03:43
Reporting Period:: 2021-04-01

Accepted Time:: 2021-04-02 18:03:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1434316	Fate Therapeutics Inc	FATE	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1655472	Cindy Tahl	C/O Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-04-01	28,149	$2.90	136,197	No	4	M	Direct
Common Stock	Acquisiton	2021-04-01	1,851	$7.87	138,048	No	4	M	Direct
Common Stock	Disposition	2021-04-01	1,000	$80.49	137,048	No	4	S	Direct
Common Stock	Disposition	2021-04-01	8,220	$81.48	128,828	No	4	S	Direct
Common Stock	Disposition	2021-04-01	4,556	$82.69	124,272	No	4	S	Direct
Common Stock	Disposition	2021-04-01	3,490	$83.40	120,782	No	4	S	Direct
Common Stock	Disposition	2021-04-01	2,200	$84.48	118,582	No	4	S	Direct
Common Stock	Disposition	2021-04-01	4,835	$85.98	113,747	No	4	S	Direct
Common Stock	Disposition	2021-04-01	5,299	$86.76	108,448	No	4	S	Direct
Common Stock	Disposition	2021-04-01	400	$87.45	108,048	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-04-01	28,149	$0.00	28,149	$2.90
Common Stock	Stock Option Right to Buy	Disposition	2021-04-01	1,851	$0.00	1,851	$7.87

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-01-07	No	4	M	Direct
10,458		2023-08-12	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020.
Represents the weighted average sale price of the shares sold ranging from $80.02 to $81.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 9.
Represents the weighted average sale price of the shares sold ranging from $81.02 to $81.85 per share.
Represents the weighted average sale price of the shares sold ranging from $82.08 to $83.07 per share.
Represents the weighted average sale price of the shares sold ranging from $83.08 to $84.06 per share.
Represents the weighted average sale price of the shares sold ranging from $84.08 to $84.97 per share.
Represents the weighted average sale price of the shares sold ranging from $85.34 to $86.33 per share.
Represents the weighted average sale price of the shares sold ranging from $86.34 to $87.32 per share.
Represents the weighted average sale price of the shares sold ranging from $87.36 to $87.53 per share.
The shares subject to this option vested in 48 equal monthly installments beginning on February 8, 2016.
1/2 of the shares subject to this option vested in 48 equal monthly installments beginning on November 4, 2013. The remaining 1/2 of the shares are divided into five equal parts, and 1/5 of such remaining shares vested in 24 equal monthly installments following the Issuer's achievement of one of the five specified performance based milestones.